Study of a new medicine for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called HS-20094 for people with type 2 diabetes. It aims to see if it helps lower blood sugar and may also help with weight. You may be able to join if you are currently on metformin or metformin plus an SGLT-2 inhibitor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes and your HbA1c (average blood sugar) is between 7.5% and 11.0%.
- You have been taking a stable dose of metformin (at least 1000 mg daily) for the last 3 months, or metformin plus an SGLT-2 inhibitor.
- Your body mass index (BMI) is 23 or higher.
- You do not have high blood pressure that is uncontrolled (systolic over 160 or diastolic over 100).
- You do not have type 1 diabetes or other specific types of diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests a once-weekly injection (HDM1005) to see if it improves blood sugar control in people with type 2 diabetes who are already taking metformin alone or with an SGLT2 inhibitor. It may help lower your A1C levels and manage your weight.
This trial tests an investigational drug called UBT251 for people with type 2 diabetes whose blood sugar is not well controlled despite taking metformin, either alone or with another diabetes medicine. The goal is to see if it can lower blood sugar levels more than a placebo.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.